Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken J Ishii

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[Nucleic Acid-based Immuno-prophylaxis and -therapies against Tropical Diseases]Ken J Ishii
Journal of Clinical Immunology|March 21, 2007
Toll or toll-free adjuvant path toward the optimal vaccine developmentKen J Ishii, Shizuo Akira
Current Infectious Disease Reports|October 6, 2004
Toll-like Receptors and SepsisKen J Ishii, Shizuo Akira
Vaccine|October 23, 2012
Adjuvants in influenza vaccinesKohhei Tetsutani, Ken J Ishii
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|February 4, 2017
Particulates Induce Type-2 Immune ResponsesEtsushi Kuroda, Ken J Ishii
Frontiers in Cell and Developmental Biology|March 1, 2021
Primary Cilia in the Skin: Functions in Immunity and Therapeutic PotentialManami Toriyama, Ken J Ishii
Current Opinion in Virology|May 2, 2026
STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challengesBurcu Temizoz, Ken J Ishii
Expert Review of Vaccines|May 17, 2021
Type I and II interferons toward ideal vaccine and immunotherapyBurcu Temizoz, Ken J Ishii
Trends in Immunology|September 19, 2006
Innate immune recognition of, and regulation by, DNAKen J Ishii, Shizuo Akira
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Development and application of adjuvant immunotherapy for cancerYuji Kitahata, Ken J Ishii
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[Nucleic Acid-based Immuno-prophylaxis and -therapies against Tropical Diseases]Ken J Ishii
Journal of Clinical Immunology|March 21, 2007
Toll or toll-free adjuvant path toward the optimal vaccine developmentKen J Ishii, Shizuo Akira
Current Infectious Disease Reports|October 6, 2004
Toll-like Receptors and SepsisKen J Ishii, Shizuo Akira
Vaccine|October 23, 2012
Adjuvants in influenza vaccinesKohhei Tetsutani, Ken J Ishii
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|February 4, 2017
Particulates Induce Type-2 Immune ResponsesEtsushi Kuroda, Ken J Ishii
Frontiers in Cell and Developmental Biology|March 1, 2021
Primary Cilia in the Skin: Functions in Immunity and Therapeutic PotentialManami Toriyama, Ken J Ishii
Current Opinion in Virology|May 2, 2026
STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challengesBurcu Temizoz, Ken J Ishii
Expert Review of Vaccines|May 17, 2021
Type I and II interferons toward ideal vaccine and immunotherapyBurcu Temizoz, Ken J Ishii
Trends in Immunology|September 19, 2006
Innate immune recognition of, and regulation by, DNAKen J Ishii, Shizuo Akira
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Development and application of adjuvant immunotherapy for cancerYuji Kitahata, Ken J Ishii
Pageof 27